Three-Statement Breakdown
REVENUE UP
Revenue rose 2.6% year over year to $127.2B, and carried a 16.9% net margin.
REVENUE
+2.6%
127,239
GROSS PROFIT
—
—
NET INCOME
+69.0%
21,558
EPS (DILUTED)
—
—
| Income statement | TTM 24-09 | TTM 24-12 | TTM 25-03 | TTM 25-06 | TTM 25-09 | TTM 25-12 | TTM 26-03 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 122,060 | 122,336 | 122,934 | 123,984 | 124,480 | 125,648 | 126,528 | 127,239 | +0.6% | +2.6% | |
| SG&A | (28,507) | (28,411) | (28,535) | (28,437) | (28,933) | (28,942) | (29,113) | (29,389) | +0.9% | +3.3% | |
| Operating income | 18,994 | 19,049 | 18,956 | 19,697 | 23,700 | 24,162 | 25,066 | 25,603 | +2.1% | +30.0% | |
| Interest expense | (6,824) | (6,759) | (6,693) | (6,649) | (6,674) | (6,804) | (6,959) | (7,187) | +3.3% | +8.1% | |
| Income tax | (3,899) | (4,445) | (4,626) | (4,721) | (4,412) | (3,621) | (3,501) | (3,048) | -12.9% | -35.4% | |
| Net income | 9,056 | 10,948 | 11,854 | 12,757 | 22,245 | 21,953 | 21,431 | 21,558 | +0.6% | +69.0% | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-22 ↗